Telesis Bio (TBIO) Short Interest Ratio & Short Volume → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free TBIO Stock Alerts $4.66 +0.16 (+3.56%) (As of 10:10 AM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Telesis Bio Short Interest DataCurrent Short Interest3,600 sharesPrevious Short Interest105,100 sharesChange Vs. Previous Month-96.57%Dollar Volume Sold Short$23,392.80Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares1,680,000 sharesFloat Size8,170,000 sharesShort Percent of Float0.04%Today's Trading Volume1,819 sharesAverage Trading Volume36,059 sharesToday's Volume Vs. Average5% Short Selling Telesis Bio ? Sign up to receive the latest short interest report for Telesis Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTBIO Short Interest Over TimeTBIO Days to Cover Over TimeTBIO Percentage of Float Shorted Over Time Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Telesis Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20243,600 shares $23,392.80 -96.6%0.0%0.1 $6.50 4/15/2024105,100 shares $39,696.27 +4.7%1.2%0.1 $0.38 3/31/2024100,400 shares $44,176.00 -55.6%1.1%0.1 $0.44 3/15/2024226,300 shares $117,449.70 -33.8%2.6%0.3 $0.52 2/29/2024341,800 shares $190,895.30 +160.1%3.9%0.5 $0.56 2/15/2024131,400 shares $40,773.42 -17.4%1.5%0.1 $0.31 Get the Latest News and Ratings for TBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Telesis Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024159,100 shares $52,662.10 -66.9%1.8%0.6 $0.33 1/15/2024481,200 shares $168,275.64 -2.9%5.5%1.8 $0.35 12/15/2022133,300 shares $159,960.00 -42.6%1.6%1.8 $1.20 11/30/2022232,100 shares $336,545.00 -28.7%2.7%3.1 $1.45 11/15/2022325,700 shares $543,919.00 +22.7%3.8%4.4 $1.67 10/31/2022265,400 shares $429,948.00 +12.3%3.1%2.4 $1.62 10/15/2022236,300 shares $444,244.00 +26.5%2.7%1.7 $1.88 9/30/2022186,800 shares $310,088.00 -1.3%2.1%1 $1.66 9/15/2022189,300 shares $401,316.00 -28.9%2.2%0.5 $2.12 8/31/2022266,400 shares $511,488.00 -43.6%3.1%0.5 $1.92 8/15/2022472,600 shares $1.12 million +39.5%5.5%0.8 $2.36 7/31/2022338,900 shares $647,299.00 +0.6%3.9%0.6 $1.91 7/15/2022336,900 shares $572,730.00 -54.3%3.9%0.6 $1.70 6/30/2022736,400 shares $1.33 million -7.7%8.5%1.3 $1.80 6/15/2022797,700 shares $2.16 million -21.8%9.2%1.6 $2.71 5/31/20221,020,000 shares $4.06 million +23.0%11.7%3.6 $3.98 5/15/2022829,200 shares $3.16 million -17.1%9.5%2.8 $3.81 4/30/20221,000,000 shares $3.70 million -27.0%11.5%3 $3.70 4/15/20221,370,000 shares $6.26 million -30.8%15.8%4 $4.57 3/31/20221,980,000 shares $10.63 million +37.5%22.8%5.2 $5.37 3/15/20221,440,000 shares $13.26 million -19.1%16.6%2.2 $9.21 2/28/20221,780,000 shares $18.16 million +24.5%20.5%3 $10.20 2/15/20221,430,000 shares $13.83 million -29.2%16.5%2.4 $9.67 1/31/20222,020,000 shares $15.84 million -3.4%23.3%3.6 $7.84 1/15/20222,090,000 shares $15.76 million +104.9%24.1%3.9 $7.54 12/31/20211,020,000 shares $11.02 million +87.7%11.8%2.1 $10.80 12/15/2021543,500 shares $3.64 million +10.4%6.3%6.3 $6.70 11/30/2021492,400 shares $3.37 million +8.0%5.7%4.9 $6.84 11/15/2021456,000 shares $3.71 million -0.3%5.3%4.2 $8.13 10/29/2021457,200 shares $4.22 million -8.1%5.3%4.6 $9.24 10/15/2021497,400 shares $5.41 million +1.8%5.7%4.6 $10.87 9/30/2021488,600 shares $5.44 million +37.1%5.6%4 $11.13 9/15/2021356,400 shares $4.55 million -12.0%4.1%2.6 $12.77 8/31/2021404,900 shares $5.25 million -10.3%5.1%2.1 $12.97This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry 8/13/2021451,600 shares $6.20 million No Change5.7%2.1 $13.72 TBIO Short Interest - Frequently Asked Questions What is Telesis Bio's current short interest? Short interest is the volume of Telesis Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,600 shares of TBIO short. 0.04% of Telesis Bio's shares are currently sold short. Learn More on Telesis Bio's current short interest. What is a good short interest percentage for Telesis Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Telesis Bio's floating shares are currently sold short. Is Telesis Bio's short interest increasing or decreasing? Telesis Bio saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 3,600 shares, a drop of 96.6% from the previous total of 105,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Telesis Bio's float size? Telesis Bio currently has issued a total of 1,680,000 shares. Some of Telesis Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Telesis Bio currently has a public float of 8,170,000 shares. How does Telesis Bio's short interest compare to its competitors? 0.04% of Telesis Bio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Telesis Bio: Precipio, Inc. (0.28%), Talis Biomedical Co. (0.80%), Cue Health Inc. (0.46%), Accelerate Diagnostics, Inc. (2.51%), Singular Genomics Systems, Inc. (1.57%), Virios Therapeutics, Inc. (1.24%), AquaBounty Technologies, Inc. (4.29%), Trevena, Inc. (0.08%), XWELL, Inc. (1.78%), TRxADE HEALTH, Inc. (1.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Telesis Bio stock? Short selling TBIO is an investing strategy that aims to generate trading profit from Telesis Bio as its price is falling. TBIO shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Telesis Bio? A short squeeze for Telesis Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TBIO, which in turn drives the price of the stock up even further. How often is Telesis Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TBIO, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PRPO Short Interest TLIS Short Interest HLTH Short Interest AXDX Short Interest OMIC Short Interest VIRI Short Interest AQB Short Interest TRVN Short Interest XWEL Short Interest MEDS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TBIO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing